Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer
Number: NCT01802346 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s): |
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Number: NCT02266745 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Promontory Therapeutics Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Number: NCT02635672 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Vincerx Pharma, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Number: NCT02717156 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Southern California|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s): |
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Number: NCT02826382 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Five Eleven Pharma, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer
Number: NCT03073395 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Five Eleven Pharma, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide⢠Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Number: NCT03129139 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Minneamrita Therapeutics LLC|Translational Drug Development Sponsor Trial Information Trial Location(s) and Contact(s): |
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
Number: NCT03232164 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): University of Wisconsin, Madison Sponsor Trial Information Trial Location(s) and Contact(s): |
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
Number: NCT03392181 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Northwestern University|Progenics Pharmaceuticals, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations
Number: NCT03413995 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clovis Oncology, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Number: NCT03436745 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s): |
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Number: NCT03460977 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Pfizer Sponsor Trial Information Trial Location(s) and Contact(s): |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
Number: NCT03495427 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2|Phase 3 Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute|Progenics Pharmaceuticals, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Number: NCT03507608 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Sponsor Trial Information Trial Location(s) and Contact(s): |
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Number: NCT03556228 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): VM Oncology, LLC Sponsor Trial Information Trial Location(s) and Contact(s): |
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)
Number: NCT03663218 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Weill Medical College of Cornell University Sponsor Trial Information Trial Location(s) and Contact(s): |
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
Number: NCT03775525 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Genzada Pharmaceuticals USA, Inc.|Translational Drug Development Sponsor Trial Information Trial Location(s) and Contact(s): |
SOR-C13 in Treating Patients With Advanced Refractory Solid Tumors
Number: NCT03784677 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s): |
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
Number: NCT03824652 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Stephen Freedland|California Walnut Commission|Cedars-Sinai Medical Center Sponsor Trial Information Trial Location(s) and Contact(s): |
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
Number: NCT03824808 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 4 Sponsor(s): University of Missouri-Columbia Sponsor Trial Information Trial Location(s) and Contact(s): |
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormo
Number: NCT04071236 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1|Phase 2 Sponsor(s): National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s): |
Stereotactic Magnetic Resonance Guided Radiation Therapy
Number: NCT04115254 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors
Number: NCT04182516 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Nerviano Medical Sciences Sponsor Trial Information Trial Location(s) and Contact(s): |
Radium-223 in Biochemically Recurrent Prostate Cancer
Number: NCT04206319 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s): |
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer
Number: NCT04220983 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Weill Medical College of Cornell University Sponsor Trial Information Trial Location(s) and Contact(s): |
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
Number: NCT04267939 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Bayer Sponsor Trial Information Trial Location(s) and Contact(s): |
PK and Dose Escalation and Expansion Study of DST-2970
Number: NCT04291664 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): DisperSol Technologies, LLC|Translational Drug Development Sponsor Trial Information Trial Location(s) and Contact(s): |
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)
Number: NCT04349501 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of California, San Diego Sponsor Trial Information Trial Location(s) and Contact(s): |
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
Number: NCT04457232 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Jonsson Comprehensive Cancer Center|Prostate Cancer Foundation Sponsor Trial Information Trial Location(s) and Contact(s): |
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Number: NCT04477512 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Washington University School of Medicine|Bristol-Myers Squibb|Exelixis Sponsor Trial Information Trial Location(s) and Contact(s): |
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)
Number: NCT04486755 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): University of Maryland, Baltimore Sponsor Trial Information Trial Location(s) and Contact(s): |
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Number: NCT04513717 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): NRG Oncology|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s): |
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
Number: NCT04528199 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|FutureChem Sponsor Trial Information Trial Location(s) and Contact(s): |
Jump: MR Simulation For Radiation Therapy Master Protocol
Number: NCT04545957 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Number: NCT04586335 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Haihe Biopharma Co., Ltd. Sponsor Trial Information Trial Location(s) and Contact(s): |
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Number: NCT04597359 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Sponsor Trial Information Trial Location(s) and Contact(s): |
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer
Number: NCT04600336 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Number: NCT04606446 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Pfizer Sponsor Trial Information Trial Location(s) and Contact(s): |
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer
Number: NCT04633252 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1|Phase 2 Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sponsor Trial Information Trial Location(s) and Contact(s): |
ARX517 in Subjects With Advanced Solid Tumor
Number: NCT04662580 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Ambrx, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
Number: NCT04666129 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Myovant Sciences GmbH Sponsor Trial Information Trial Location(s) and Contact(s): |
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
Number: NCT04698564 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Maryland, Baltimore Sponsor Trial Information Trial Location(s) and Contact(s): |
TH1902 in Patients With Advanced Solid Tumors
Number: NCT04706962 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Theratechnologies|PPD Sponsor Trial Information Trial Location(s) and Contact(s): |
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
Number: NCT04709276 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Andrew J. Armstrong, MD|Bristol-Myers Squibb|Duke University Sponsor Trial Information Trial Location(s) and Contact(s): |
Open-label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer
Number: NCT04729114 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1|Phase 2 Sponsor(s): Propella Therapeutics Sponsor Trial Information Trial Location(s) and Contact(s): |
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
Number: NCT04743934 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Andrew McDonald|University of Alabama at Birmingham Sponsor Trial Information Trial Location(s) and Contact(s): |
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
Number: NCT04748042 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Michigan Rogel Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s): |
An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer
Number: NCT04777071 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Washington Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Number: NCT04821622 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Pfizer|Astellas Pharma Inc Sponsor Trial Information Trial Location(s) and Contact(s): |
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer
Number: NCT04842890 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): The New York Proton Center Sponsor Trial Information Trial Location(s) and Contact(s): |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Number: NCT04857502 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Jonsson Comprehensive Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s): |
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
Number: NCT04867603 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Norbert Avril, M.D.|Case Comprehensive Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s): |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
Number: NCT04879940 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute Sponsor Trial Information Trial Location(s) and Contact(s): |
11C-YJH08 PET Imaging for the Detection of Glucocorticoid Receptor Expression in Patients With Metastatic Prostate Cancer
Number: NCT04927663 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Michael Evans|U.S. Army Medical Research Acquisition Activity|National Institute of Mental Health (NIMH)|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s) |
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Number: NCT04995198 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Prostate Cancer Clinical Trials Consortium|Memorial Sloan Kettering Cancer Center|Fred Hutchinson Cancer Center|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Advancing Cancer Treatment, Inc. Sponsor Trial Information Trial Location(s) and Contact(s): |
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.
Number: NCT05010200 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Ashutosh Kumar Tewari|Icahn School of Medicine at Mount Sinai Sponsor Trial Information Trial Location(s) and Contact(s): |
Differences in Immunological Effects of Vitamin D Replacement Among African American Prostate Cancer Patients With Localized Versus Metastatic Disease
Number: NCT05045066 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Mayo Clinic|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s): |
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
Number: NCT05059236 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Bayer Sponsor Trial Information Trial Location(s) and Contact(s): |
Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients
Number: NCT05156372 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Not Applicable Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s): |
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
Number: NCT05160597 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Early Phase 1 Sponsor(s): Jonsson Comprehensive Cancer Center Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Number: NCT05215574 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): NGM Biopharmaceuticals, Inc|Merck Sharp & Dohme LLC Sponsor Trial Information Trial Location(s) and Contact(s): |
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
Number: NCT05288166 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 3 Sponsor(s): Eli Lilly and Company Sponsor Trial Information Trial Location(s) and Contact(s): |
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Number: NCT05413421 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): ORIC Pharmaceuticals Sponsor Trial Information Trial Location(s) and Contact(s): |
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
Number: NCT05585034 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Sponsor Trial Information Trial Location(s) and Contact(s): |